Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Not applicableStudy completedNCT05118230
What this trial is testing

Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 61
Not applicableUnknownNCT05459519
What this trial is testing

Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease

Who this might be right for
DiabetesHypertensionHypercholesterolemia
China National Center for Cardiovascular Diseases 165
Not applicableStudy completedNCT01695837
What this trial is testing

Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia

Who this might be right for
Dyslipidemia
University of Nevada, Las Vegas 61
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Large-scale testing (Phase 3)Study completedNCT00650689
What this trial is testing

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

Who this might be right for
HypercholesterolemiaAtherosclerosisCoronary Artery Disease
Organon and Co 122
Not applicableStudy completedNCT05285085
What this trial is testing

Real World Evidence Study of Statin Use in Brazil

Who this might be right for
Cardiovascular DiseasesMyocardial InfarctionStroke+3 more
Hospital Israelita Albert Einstein 2,133,900
Testing effectiveness (Phase 2)Study completedNCT01890967
What this trial is testing

LY3015014 in Participants With High Cholesterol

Who this might be right for
Hypercholesterolemia
Eli Lilly and Company 527
Not applicableStudy completedNCT06127732
What this trial is testing

Phytosterol Supplementation and Lipoprotein Subfractions

Who this might be right for
HypercholesterolemiaPrimary Prevention
Federal University of São Paulo 23
Post-approval studies (Phase 4)Study completedNCT00242944
What this trial is testing

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

Who this might be right for
Coronary DiseaseHypercholesterolemia
Kyoto University 307
Large-scale testing (Phase 3)Study completedNCT00257686
What this trial is testing

Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

Who this might be right for
Hypercholesterolemia or Combined Dyslipidemia
Kowa Research Europe 962
Testing effectiveness (Phase 2)Study completedNCT00603590
What this trial is testing

Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease

Who this might be right for
Cardiovascular DiseaseHypertensionHyperlipidemia+1 more
Tehran University of Medical Sciences 475
Large-scale testing (Phase 3)Study completedNCT01154036
What this trial is testing

MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

Who this might be right for
Hypercholesterolemia
Organon and Co 1,547
Post-approval studies (Phase 4)Study completedNCT00708370
What this trial is testing

Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.

Who this might be right for
Dyslipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 297
Large-scale testing (Phase 3)Ended earlyNCT01274559
What this trial is testing

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,173
Large-scale testing (Phase 3)Looking for participantsNCT07614958
What this trial is testing

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Who this might be right for
Mixed DyslipidemiaHypercholesterolaemia
A. Menarini International Licensing S.A. 426
Not applicableLooking for participantsNCT06770543
What this trial is testing

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 1,500
Post-approval studies (Phase 4)Study completedNCT00650663
What this trial is testing

Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 247
Testing effectiveness (Phase 2)Study completedNCT02278471
What this trial is testing

The SCCS Polypill Pilot Trial

Who this might be right for
HypertensionHyperlipidemia
Vanderbilt University 303
Very early researchStudy completedNCT05682911
What this trial is testing

Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients

Who this might be right for
The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients
Jinnah Sindh Medical University 40
Next Page